Segar J L, Minnick A, Nuyt A M, Robillard J E
Department of Pediatrics, University of Iowa, Iowa City 52242, USA.
Am J Physiol. 1997 Jun;272(6 Pt 2):R1862-73. doi: 10.1152/ajpregu.1997.272.6.R1862.
The present study was designed to test the hypothesis that endogenous angiotensin II (ANG II) influences baroreflex control of heart rate (HR) and renal sympathetic nerve activity (RSNA) early in life and to determine whether these actions are mediated by angiotensin AT1 or AT2 receptors. To test this hypothesis, we studied the effects of systemic and central administration of losartan, a selective AT1 receptor antagonist, and PD-123319, a selective AT2 antagonist, on baroreflex-mediated control of HR and RSNA in conscious newborn lambs. Systemic administration of losartan decreased resting mean arterial blood pressure (MABP) from 70 +/- 3 to 58 +/- 4 mmHg (P < 0.05) without producing reflex increases in HR or RSNA. The baroreflex response curves were shifted to the left as indicated by a decrease in the arterial pressure at the midpoint of the curve for HR (83 +/- 3 to 75 +/- 4 mmHg) and RSNA (74 +/- 2 to 69 +/- 3 mmHg; P < 0.05 for both). Losartan also reset HR and RSNA baroreflex curves when changes in baseline blood pressure were prevented by simultaneous infusion of phenylephrine. In contrast, a sustained decrease in arterial pressure of 10-12 mmHg with nitroprusside failed to shift the baroreflex function curves. PD-123319 had no effect on baseline HR, MABP, RSNA, or baroreflex responses. Lateral ventricle administration of losartan but not PD-123319 also produced a decrease in arterial pressure (81 +/- 4 to 73 +/- 3 mmHg, P < 0.05) and reset the baroreflex for HR and RSNA toward lower pressure. These results demonstrate that, early in life, endogenous ANG II exerts a tonic effect on baroreflex control of HR and RSNA to shift the curves toward higher pressure levels. The alterations in arterial baroreflex function appear independent of direct ANG II effects on arterial pressure and are mediated by AT1 receptors.
内源性血管紧张素II(ANG II)在生命早期会影响心率(HR)和肾交感神经活动(RSNA)的压力感受性反射控制,并确定这些作用是否由血管紧张素AT1或AT2受体介导。为验证该假设,我们研究了选择性AT1受体拮抗剂氯沙坦和选择性AT2拮抗剂PD - 123319全身及中枢给药对清醒新生羔羊压力感受性反射介导的HR和RSNA控制的影响。氯沙坦全身给药使静息平均动脉血压(MABP)从70±3 mmHg降至58±4 mmHg(P<0.05),但未引起HR或RSNA的反射性增加。压力感受性反射反应曲线向左移位,HR曲线中点的动脉压从83±3 mmHg降至75±4 mmHg,RSNA曲线中点的动脉压从74±2 mmHg降至69±3 mmHg(两者P均<0.05)。当通过同时输注去氧肾上腺素防止基线血压变化时,氯沙坦也使HR和RSNA压力感受性反射曲线重置。相反,硝普钠使动脉压持续降低10 - 12 mmHg未能使压力感受性反射功能曲线移位。PD - 123319对基线HR、MABP、RSNA或压力感受性反射反应无影响。侧脑室注射氯沙坦而非PD - 123319也使动脉压降低(81±4 mmHg降至73±3 mmHg,P<0.05),并使HR和RSNA的压力感受性反射向较低压力重置。这些结果表明,在生命早期,内源性ANG II对HR和RSNA的压力感受性反射控制发挥紧张性作用,使曲线向更高压力水平移位。动脉压力感受性反射功能的改变似乎与ANG II对动脉压的直接作用无关,且由AT1受体介导。